LIPOSOMAL PROSTAGLANDIN FORMULATIONS

A method of treating a cell activation/adhesion syndrome in mammals, including humans, by the administration of a pros-taglandin associated with a liposome is disclosed. Such cell activation/adhesion syndromes may include reperfusion injury, sep-tic shock, myocardial infarction, adult respiratory di...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: OSTRO, MARC J
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:A method of treating a cell activation/adhesion syndrome in mammals, including humans, by the administration of a pros-taglandin associated with a liposome is disclosed. Such cell activation/adhesion syndromes may include reperfusion injury, sep-tic shock, myocardial infarction, adult respiratory distress syndrome, rheumatoid vasculitis, systemic vasculitis, lupus, post trau-matic shock, burn injury or restenosis after angioplasty. In a preferred embodiment, the prostaglandin is encapsulated in the liposomes.